Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01264276 · ClinicalTrials.gov registry record

Telemedicine Approaches to Evaluating Acute-phase ROP

A clinical trial, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
269
Enrollment target

NCT01264276: Completed study, sponsored by Children's Hospital of Philadelphia.

NCT01264276 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 269 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01264276 has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
269 participants
Enrollment target

Study Summary

The primary objective of this multi-center clinical study is to evaluate the validity, reliability, feasibility, safety and relative cost-effectiveness of a retinopathy of prematurity (ROP) telemedicine evaluation system to detect eyes of at-risk babies who meet referral warranted ROP (RW-ROP) criteria and therefore need a diagnostic evaluation by an ophthalmologist experienced in ROP. We shall: 1. Calculate the accuracy, using sensitivity and specificity, of the system to provide remote evaluations when compared with the findings of a "gold standard" indirect ophthalmoscopic examination performed by a Study-certified ophthalmologist, rigorously trained in ROP diagnostic examinations (validity); 2. Determine intra-reader and inter-reader agreement for deciding whether digital images indicate that the eyes of a baby are in need of diagnostic indirect ophthalmoscopy by an ophthalmologist experienced in ROP (reliability); 3. Determine whether imaging evaluation can be achieved for each baby (feasibility); 4. Examine ocular and systemic complications associated with digital imaging and compared with those associated with diagnostic examinations performed by an ophthalmologist (safety); 5. Compare the costs and benefits of adopting a telemedicine retinal imaging system compared to the current cost of indirect ophthalmoscopic examinations (cost-effectiveness).

Trial Details

FieldValue
Enrollment Target 269 participants
Start Date 2011-07
Est. Completion 2014-01
Children's Hospital of Philadelphia

431 total trials

What the finished NCT01264276 record still lists

NCT01264276 is an observational study that tracks outcomes without assigning an intervention. The registered 269 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01264276 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01264276 about?

NCT01264276 is a clinical study titled "Telemedicine Approaches to Evaluating Acute-phase ROP". The primary objective of this multi-center clinical study is to evaluate the validity, reliability, feasibility, safety and relative cost-effectiveness of a retinopathy of prematurity (ROP) telemedicine evaluation system to detect eyes of at-risk babies who meet referral warranted ROP (RW-ROP) crite...

What is the current status of trial NCT01264276?

This trial is currently completed. The enrollment target is 269 participants. The study started on 2011-07. Estimated completion is 2014-01.

Who is sponsoring clinical trial NCT01264276?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04802291 · 269 participants · NA

    HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity

  • NCT06500455 · 269 participants · Phase 3

    Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

  • NCT06630676 · 269 participants · NA

    The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain

  • NCT00801489 · 270 participants · Phase 2

    Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01264276, the US trial registry maintained by the National Library of Medicine. NCT01264276 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.